Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIBOCICLIB vs RIFAMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIBOCICLIB vs RIFAMYCIN: Safety Overview

Metric RIBOCICLIB RIFAMYCIN
Total FAERS Reports 27,997 106
Deaths Reported 4,501 26
Death Rate 16.1% 24.5%
Hospitalizations 6,700 35
Average Patient Age 60.2 yrs 56.1 yrs
% Female Patients 99.0% 54.5%
FDA Approval Date Mar 13, 2017 Nov 16, 2018
Manufacturer Novartis Pharmaceuticals Corporation N/A
Route ORAL N/A
Marketing Status Prescription Discontinued